UNKNOWN_NEUWAVE
Report
- Report Number
- 3008769756-2019-00055
- Event Type
- Injury
- Date Received
- December 20, 2019
- Date of Event
- January 1, 2013
- Report Date
- December 2, 2019
- Manufacturer
- NEUWAVE MEDICAL, INC.
- Product Code
- NEY
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
(B)(4). DATE OF EVENT: PUBLICATION YEAR OF 2013. THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE LOT HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. (B)(4).
IT WAS REPORTED VIA LITERATURE ENTITLED: PERCUTANEOUS HEPATIC MICROWAVE ABLATION WITH HIGH-POWERED, GAS COOLED ANTENNAS: SHORT TERM RESULTS IN 87 PATIENTS AUTHORS: ZIEMLEWICZ T., HINSHAW J., LUBNER M., BRACE C., SAMPSON L., CENTER M. CITATION: JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2013 JAN; CONFERENCE: SYMPOSIUM ON CLINICAL INTERVENTIONAL ONCOLOGY, CIO 2013. MIAMI BEACH, FL UNITED STATES. 24 (1) :145.E31-145.E32. THE PURPOSE OF THIS RETROSPECTIVE STUDY WAS TO REVIEW THE RESULTS IN THE FIRST 87 PATIENTS WITH MALIGNANT HEPATIC TUMORS TREATED WITH A NEW HIGH-POWER, GAS-COOLED MICROWAVE (MW) ABLATION DEVICE. BETWEEN DECEMBER 2010 AND SEPTEMBER 2012, 87 PATIENTS WERE ENROLLED IN THE STUDY. ALL PROCEDURES WERE PERFORMED WITH A HIGH-POWERED, GAS-COOLED MICROWAVE SYSTEM (CERTUS 140, NEUWAVE MEDICAL, MADISON, WI) UTILIZING 1-3 17-GAUGE ANTENNAS. REPORTED COMPLICATION INCLUDED RIGHT PLEURAL EFFUSION (N=2) REQUIRING THORACENTESIS FOR SYMPTOMATIC RELIEF; PORTAL VEIN CLOT (N=1) REQUIRING ANTI-COAGULATION. IN CONCLUSION, EARLY EXPERIENCE TREATING LIVER TUMORS USING A HIGH-POWERED, GAS-COOLED MICROWAVE ABLATION SYSTEM DEMONSTRATES EXCELLENT LOCAL CONTROL WITH MINIMAL COMPLICATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1298903 | UNKNOWN_NEUWAVE | SYSTEM, ABLATION, MICROWAVE AND ACCESSORIES | NEY | NEUWAVE MEDICAL, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |